Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases

14 Aug 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Cell Function and Interaction
Share to Monoclonal and Polyclonal Antibodies Research
Share to T-cell and B-cell Immunology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39146891
DOI: 10.1016/j.jaut.2024.103291

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseasesPMID 39146891Read ↗

The Future of Systemic Lupus Erythematosus Treatment: The Promise of Selective Immunotherapies, Anifrolumab and Belimumab, Compared to Blanket ImmunosuppressivesSemantic proximity Read ↗

IVIG in autoimmune disease — Potential next generation biologicsSemantic proximity Read ↗

COVID-19 in patients with rheumatological diseases treated with anti-TNFSemantic proximity Read ↗

Rationale for CD40 pathway blockade in autoimmune rheumatic disordersSemantic proximity Read ↗

Risankizumab: Mechanism of action, clinical and translational scienceSemantic proximity Read ↗

Rapid clinical and transcriptomic response to anifrolumab in refractory anti-TIF1γ–positive juvenile dermatomyositisSemantic proximity Read ↗

Tyk2 Targeting in Immune-Mediated Inflammatory DiseasesSemantic proximity Read ↗

Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid deliverySemantic proximity Read ↗

Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomesSemantic proximity Read ↗

T cells as therapeutic targets in SLESemantic proximity Read ↗

The Oncology: Disease Modifying Anti-Rheumatic Drug Interface: A Cross-Specialty ReviewSemantic proximity Read ↗

TNF ligands and receptors in autoimmunity: an updateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.